The study further demonstrated that IL-4 signaling operates within distinct TME neighborhoods, where even a small fraction of IL-4-producing ovarian cancer cells can exert a significant impact on the surrounding immune landscape. The gene discussed is IL4; the disease is ovarian carcinoma.